MacPherson A - Search Results

1

Patient Participation in Clinical Trials of Oncology Drugs and Biologics Preceding Approval by the US Food and Drug Administration.

Hutchinson N, Carlisle B, Doussau A, Bosan R, Gumnit E, MacPherson A, Fergusson DA, Kimmelman J. Hutchinson N, et al. Among authors: macpherson a. JAMA Netw Open. 2021 May 3;4(5):e2110456. doi: 10.1001/jamanetworkopen.2021.10456. JAMA Netw Open. 2021. PMID: 34003270 Free PMC article.

2

Ethical development of stem-cell-based interventions.

MacPherson A, Kimmelman J. MacPherson A, et al. Nat Med. 2019 Jul;25(7):1037-1044. doi: 10.1038/s41591-019-0511-6. Epub 2019 Jul 3. Nat Med. 2019. PMID: 31270501 Review.

3

Risks and benefits of unapproved disease-modifying treatments for neurodegenerative disease.

Feustel AC, MacPherson A, Fergusson DA, Kieburtz K, Kimmelman J. Feustel AC, et al. Among authors: macpherson a. Neurology. 2020 Jan 7;94(1):e1-e14. doi: 10.1212/WNL.0000000000008699. Epub 2019 Dec 2. Neurology. 2020. PMID: 31792092 Free PMC article.

4

Probability of Success and Timelines for the Development of Vaccines for Emerging and Reemerged Viral Infectious Diseases.

MacPherson A, Hutchinson N, Schneider O, Oliviero E, Feldhake E, Ouimet C, Sheng J, Awan F, Wang C, Papenburg J, Basta NE, Kimmelman J. MacPherson A, et al. Ann Intern Med. 2021 Mar;174(3):326-334. doi: 10.7326/M20-5350. Epub 2020 Nov 24. Ann Intern Med. 2021. PMID: 33226855 Free PMC article.

5

Quantifying Patient Investment in Novel Neurological Drug Development.

MacPherson A, Gumnit E, Ouimet C, Hutchinson N, Kieburtz K, Pearson TS, Kimmelman J. MacPherson A, et al. Neurotherapeutics. 2022 Sep;19(5):1507-1513. doi: 10.1007/s13311-022-01259-y. Epub 2022 Jun 28. Neurotherapeutics. 2022. PMID: 35764764 Free PMC article.

6

Principal investigators over-optimistically forecast scientific and operational outcomes for clinical trials.

Benjamin DM, Hey SP, MacPherson A, Hachem Y, Smith KS, Zhang SX, Wong S, Dolter S, Mandel DR, Kimmelman J. Benjamin DM, et al. Among authors: macpherson a. PLoS One. 2022 Feb 8;17(2):e0262862. doi: 10.1371/journal.pone.0262862. eCollection 2022. PLoS One. 2022. PMID: 35134071 Free PMC article.

7

Wisdom of the expert crowd prediction of response for 3 neurology randomized trials.

Atanasov P, Diamantaras A, MacPherson A, Vinarov E, Benjamin DM, Shrier I, Paul F, Dirnagl U, Kimmelman J. Atanasov P, et al. Among authors: macpherson a. Neurology. 2020 Aug 4;95(5):e488-e498. doi: 10.1212/WNL.0000000000009819. Epub 2020 Jun 16. Neurology. 2020. PMID: 32546652 Free PMC article.

8

Expert Forecasts of COVID-19 Vaccine Development Timelines.

Kane PB, Moyer H, MacPherson A, Papenburg J, Ward BJ, Broomell SB, Kimmelman J. Kane PB, et al. Among authors: macpherson a. J Gen Intern Med. 2020 Dec;35(12):3753-3755. doi: 10.1007/s11606-020-06244-9. Epub 2020 Sep 28. J Gen Intern Med. 2020. PMID: 32989715 Free PMC article. No abstract available.

9

Relationship between lay and expert perceptions of COVID-19 vaccine development timelines in Canada and USA.

Kane PB, Moyer H, MacPherson A, Papenburg J, Ward BJ, Broomell SB, Kimmleman J. Kane PB, et al. Among authors: macpherson a. PLoS One. 2022 Feb 15;17(2):e0262740. doi: 10.1371/journal.pone.0262740. eCollection 2022. PLoS One. 2022. PMID: 35167591 Free PMC article.

10

Lionfish venom elicits pain predominantly through the activation of nonpeptidergic nociceptors.

Mouchbahani-Constance S, Lesperance LS, Petitjean H, Davidova A, Macpherson A, Prescott SA, Sharif-Naeini R. Mouchbahani-Constance S, et al. Among authors: macpherson a. Pain. 2018 Nov;159(11):2255-2266. doi: 10.1097/j.pain.0000000000001326. Pain. 2018. PMID: 29965829

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

742 results

Search Page

Filters